Tag: biotechnology
-
Moderna Developing Flu, HIV, Nipah Vaccines
Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases.
-
Drug Price Disruptor Biotech Raises $500M in New Funds
A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round.
-
Vaccine Shown Active Against New Covid-19 Variants
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K.
-
CureVac, Bayer Partner on Covid-19 Vaccine Supply
Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine.
-
Synthetic Biology Company Raises $105M in New Funds
A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round.
-
Synthetic Virus Company Forms, Raises $77M
A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute.
-
FDA Issues Precision Genomic Drug Guidance
The U.S. Food and Drug Administration issued draft administrative and procedural guidelines for genetic disorders treated with precise gene therapies.
-
Trial OKed for Rare Disease Gene Therapy
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease.
-
A Look Back at 2020 on Science & Enterprise
Historians will record 2020 as a pivotal and dangerous time, and our corner of that world at the intersection of science and business played a visible role in it.
-
Large Covid-19 Vaccine Trial Underway in U.S.
A biotechnology vaccine developer began enrolling participants in a large-scale clinical trial testing a vaccine to prevent Covid-19 infections.